back to cluster viewer
cluster path 001011110110
50 words, 25,055 tokens
freq alpha suffix
Words in frequency order
1 | design | 24,981
|
2 | ca184-022 | 5
|
3 | d9803 | 5
|
4 | 26981 | 4
|
5 | self-realization | 4
|
6 | 8894 | 3
|
7 | hypo-osmolarity | 3
|
8 | jhqg | 3
|
9 | 0617 | 2
|
10 | 1-ter | 2
|
11 | design- | 2
|
12 | postiaalni | 2
|
13 | stride-1 | 2
|
14 | 'placebo'-controlled | 1
|
15 | 0036 | 1
|
16 | 10981/22023 | 1
|
17 | 24891 | 1
|
18 | 372a | 1
|
19 | 6372 | 1
|
20 | 792014 | 1
|
21 | 9404 | 1
|
22 | ai424-360 | 1
|
23 | and-after | 1
|
24 | aost06b1 | 1
|
25 | arbitr | 1
|
26 | arm-28 | 1
|
27 | biopenetration | 1
|
28 | ca184024 | 1
|
29 | ccg-101 | 1
|
30 | cmx001-102 | 1
|
31 | considered.naltrexone | 1
|
32 | design.effects | 1
|
33 | design.participants | 1
|
34 | group-8 | 1
|
35 | group.flexibility | 1
|
36 | hbbr | 1
|
37 | interherz | 1
|
38 | lab-study | 1
|
39 | medications/mm | 1
|
40 | nct00501579 | 1
|
41 | p63mc | 1
|
42 | photogradings | 1
|
43 | rightward-shift | 1
|
44 | tick-infestation | 1
|
45 | tooth/site | 1
|
46 | tr701-103 | 1
|
47 | tr701-108 | 1
|
48 | trial.only | 1
|
49 | trials-benchmrk-1 | 1
|
50 | uro-bcg-4 | 1
|
Words in alphabetical order
1 | 'placebo'-controlled | 1
|
2 | 0036 | 1
|
3 | 0617 | 2
|
4 | 1-ter | 2
|
5 | 10981/22023 | 1
|
6 | 24891 | 1
|
7 | 26981 | 4
|
8 | 372a | 1
|
9 | 6372 | 1
|
10 | 792014 | 1
|
11 | 8894 | 3
|
12 | 9404 | 1
|
13 | ai424-360 | 1
|
14 | and-after | 1
|
15 | aost06b1 | 1
|
16 | arbitr | 1
|
17 | arm-28 | 1
|
18 | biopenetration | 1
|
19 | ca184-022 | 5
|
20 | ca184024 | 1
|
21 | ccg-101 | 1
|
22 | cmx001-102 | 1
|
23 | considered.naltrexone | 1
|
24 | d9803 | 5
|
25 | design | 24,981
|
26 | design- | 2
|
27 | design.effects | 1
|
28 | design.participants | 1
|
29 | group-8 | 1
|
30 | group.flexibility | 1
|
31 | hbbr | 1
|
32 | hypo-osmolarity | 3
|
33 | interherz | 1
|
34 | jhqg | 3
|
35 | lab-study | 1
|
36 | medications/mm | 1
|
37 | nct00501579 | 1
|
38 | p63mc | 1
|
39 | photogradings | 1
|
40 | postiaalni | 2
|
41 | rightward-shift | 1
|
42 | self-realization | 4
|
43 | stride-1 | 2
|
44 | tick-infestation | 1
|
45 | tooth/site | 1
|
46 | tr701-103 | 1
|
47 | tr701-108 | 1
|
48 | trial.only | 1
|
49 | trials-benchmrk-1 | 1
|
50 | uro-bcg-4 | 1
|
Words in suffix order
1 | design- | 2
|
2 | ai424-360 | 1
|
3 | stride-1 | 2
|
4 | trials-benchmrk-1 | 1
|
5 | ccg-101 | 1
|
6 | 26981 | 4
|
7 | 24891 | 1
|
8 | aost06b1 | 1
|
9 | cmx001-102 | 1
|
10 | ca184-022 | 5
|
11 | 6372 | 1
|
12 | tr701-103 | 1
|
13 | d9803 | 5
|
14 | 10981/22023 | 1
|
15 | uro-bcg-4 | 1
|
16 | 9404 | 1
|
17 | 792014 | 1
|
18 | ca184024 | 1
|
19 | 8894 | 3
|
20 | 0036 | 1
|
21 | 0617 | 2
|
22 | group-8 | 1
|
23 | tr701-108 | 1
|
24 | arm-28 | 1
|
25 | nct00501579 | 1
|
26 | 372a | 1
|
27 | p63mc | 1
|
28 | 'placebo'-controlled | 1
|
29 | considered.naltrexone | 1
|
30 | tooth/site | 1
|
31 | jhqg | 3
|
32 | postiaalni | 2
|
33 | medications/mm | 1
|
34 | design | 24,981
|
35 | biopenetration | 1
|
36 | tick-infestation | 1
|
37 | self-realization | 4
|
38 | hbbr | 1
|
39 | 1-ter | 2
|
40 | and-after | 1
|
41 | arbitr | 1
|
42 | photogradings | 1
|
43 | design.effects | 1
|
44 | design.participants | 1
|
45 | rightward-shift | 1
|
46 | lab-study | 1
|
47 | trial.only | 1
|
48 | group.flexibility | 1
|
49 | hypo-osmolarity | 3
|
50 | interherz | 1
|